Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
US Department of Justice
Chinese Patent Office
Federal Trade Commission
US Army
Baxter
Harvard Business School
Queensland Health

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,895,726

« Back to Dashboard

Summary for Patent: 4,895,726
Title: Novel dosage form of fenofibrate
Abstract:The present invention relates to a novel dosage form of fenofibrate containing fenofibrate and a solid surfactant which have been co-micronized. It also relates to the method for the preparation of this dosage form and its use for improving the bioavailabity in vivo.
Inventor(s): Curtet; Bernard (Marsanny la Cote, FR), Teillaud; Eric (Talant, FR), Reginault; Philippe (Fontaine les Dijon, FR)
Assignee: Fournier Innovation et Synergie (Paris, FR)
Application Number:07/299,073
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,895,726
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 4,895,726

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,895,726

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France88 02359Feb 26, 1988

International Family Members for US Patent 4,895,726

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 83374 ➤ Try a Free Trial
Australia 2982889 ➤ Try a Free Trial
Australia 614577 ➤ Try a Free Trial
Canada 1322529 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Farmers Insurance
Queensland Health
UBS
Accenture
Fish and Richardson
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.